companiesCompany
Sirtex Medical
Sirtex makes SIR-Spheres, yttrium-90 resin microspheres used for radioembolisation of liver tumours.
SIR-Spheres are indicated for unresectable metastatic colorectal cancer to the liver (US) and HCC (CE mark, DOORwaY90 trial supporting a US HCC indication). Competes with Boston Scientific's TheraSphere glass microspheres. Owned by China Grand Pharmaceutical.